Skip to content

Effects of Insole Vibration With Proprioceptive Training in Patients With Diabetic Peripheral Neuropathy

Effects of Insole Vibration With Proprioceptive Training on Balance and Functional Ability in Patients With Diabetic Peripheral Nuropathy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07128836
Enrollment
60
Registered
2025-08-19
Start date
2025-04-10
Completion date
2025-08-15
Last updated
2025-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Peripheral Neuropathy (DPN)

Keywords

Diabetic polyneuropathy, Vibrating insole,, Proprioceptive training, Balance

Brief summary

Diabetic peripheral neuropathy (DPN) is a prevalent complication of diabetes, profoundly affecting quality of life with sensory disturbances and associated complications. Proprioceptive training shows promise in improving proprioception and functional outcomes in patients with peripheral neuropathy. Also the literature has shown that Insole vibrator demonstrates potential in mitigating symptoms and improving sensory function and balance in patients with peripheral neuropathy. This study aims to determine the effects of insole vibration with proprioceptive training on balance and functional ability in patient with diabetic peripheral neuropathy. In this randomized controlled trial design, 60 participants will be recruited. The sample size was calculated through G-power total of 60 participants. Who meet the inclusion criteria will be recruited through non-probability convenience sampling technique, which will further be randomized through online randomizer tool into control and experimental group with thirty participants in each group. Experimental group will receive proprioceptive training alongside vibrating insole and control group will receive proprioceptive training with non vibrating insoles. Data will be collected by using various assessment tools, including Numeric Pain Rating Scale for pain,Time Up And Go Test for functional mobility, Neuropathic Disability Score for level of disability ,Functional Reach Test for standing stability, Mini BESTS for balance, functional mobility and gait, Single Leg Stance Test for static posture and balance control and the Montreal Cognitive Assessment for cognitive impairment. Pre-intervention assessments will be conducted for both groups. The effects of the interventions will be measured at pre-treatment, 6th week, 12th week and at 16th week. Data analysis will be performed by using SPSS 26. Mixed ANOVA and repeated-measures ANOVA will use for within-group analysis whereas between-group analysis will perform by using one-way ANOVA. Key words: Diabetic polyneuropathy, Vibrating insole, proprioceptive training, balance

Interventions

OTHERproprioceptive training exercise and receive insole vibrator

The treatment for the participants in the experimental group includes; 5 minutes warm up, 30 minutes proprioceptive training exercise, 20 minutes walk with in-sole vibrator, 5 minutes cool down. The duration of each session will be 60 minutes. All the participants will receive 36 sessions (3 times per week over 12 week's period).

OTHERproprioceptive training exercise along with simple insoles without vibration

The treatment for the participants in the control group includes; 5 minutes warm up, 30 minutes proprioceptive training exercise, 20 minutes walk with non-vibrating insole, 5 minutes cool down. The duration of each session will be 60 minutes. All the participants will receive 36 sessions (3 times per week over 12 week's period).

Sponsors

Riphah International University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
50 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* • Patients with both genders male and female will be included * The age limit for the patients will be from 50 to 70 years * Patients diagnosed with DPN type 1 or type 2 * Patients with neuropathic disability score greater than 3 will be included * Patients with Michigan questionnaire higher than 3 * Patients who can walk independently with BBS score between 41 to 56

Exclusion criteria

* Patients with Mini Mental State less than 24 * Patients having Numeric Pain Rating Scale greater than 4 * Patients with any impairment in lower leg e.g; Leg Length Discrepancy, foot ulcer, lower limb injury

Design outcomes

Primary

MeasureTime frameDescription
Numeric Pain Rating Scale (NPRS)Baseline after completion of 6 and 8 weeksto measure pain scale range 0-10. zero means no pain 10 means maximum
Time Up and Go (TUG) TestBaseline after completion of 6 and 8 weeksTo measure mobility and fall risk (time to rise, walk, return) measure in seconds time \> 20 sec means impaired mobility
Neuropathic Disability score (NDS)Baseline after completion of 6 and 8 weeksSeverity of PND (0-10 scale) 0 means no disability 10 means maximum disability
Functional Reach test (FRT)Baseline after completion of 6 and 8 weeksto measure anticipatory postural control Stability and fall risk
Mini-BESTestBaseline after completion of 6 and 8 weeksto measure static and dynamic balance (0-30 scale) greater score means better mobility

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026